Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-year Results from a Comparative Effectiveness Randomized Clinical Trial

PURPOSE: Provide 2-year efficacy, safety and treatment results comparing three anti-vascular endothelial growth factor (anti-VEGF) agents for center-involved diabetic macular edema (DME) utilizing a standardized follow-up and retreatment regimen. DESIGN: Randomized clinical trial. PARTICIPANTS: 660...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ophthalmology
Asıl Yazarlar: Wells, John A., Glassman, Adam R., Ayala, Allison R., Jampol, Lee M., Bressler, Neil M., Bressler, Susan B., Brucker, Alexander J., Ferris, Frederick L., Hampton, G. Robert., Jhaveri, Chirag, Melia, Michele, Beck, Roy W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4877252/
https://ncbi.nlm.nih.gov/pubmed/26935357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2016.02.022
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller